Antidepressant

Nearly 1 in 5 adults with elevated BP also take a medication that could be raising their BP, according to a presentation at the American College of Cardiology Scientific Session.

Delivery of a psychological intervention during a patient’s antidepressant tapering may be an alternative long-term antidepressant use for treating recurrent depression, according to study results published in JAMA Psychiatry.

Stephen Ross, MD, associate director of NYU Langone Center for Psychedelic Medicine, provided an overview of data on psilocybin for treating depression and anxiety at the American Psychiatric Association’s annual meeting.

Empirical support appeared lacking for personalizing antidepressant treatment based entirely on total depression scores, according to results of a meta-analysis of placebo-controlled randomized clinical trials published in JAMA Psychiatry.

Use of the antidepressant fluvoxamine in patients with COVID-19 was associated with a slightly lower likelihood of clinical deterioration over 15 days in a small study, according to results published in JAMA.

As part of its public health mission, FDA has been monitoring for adverse effects from opioids and opioid-like substances for years. Two recent examples of concern are loperamide and kratom.

Psychotropic adverse events that affect medication adherence are often non-life threatening and easy to treat, according to a presenter at the NEI Max Virtual Conference.

Mirtazapine monotherapy did not appear efficacious for treating PTSD, according to results of a randomized, placebo-controlled trial published in Journal of Clinical Psychiatry.

Co-prescribed benzodiazepines appeared to present treatment challenges among older adults with generalized anxiety disorder or major depressive disorder, according to study results published in Journal of Clinical Psychiatry.

Adults with depression who initiated augmentation with newer antipsychotics appeared at increased risk for mortality vs. those who added a second antidepressant, according to results of a population-based cohort study published in PLOS ONE.